LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Search

Omnicell Inc

Fechado

SetorSaúde

38.59 3.43

Visão Geral

Variação de preço das ações

24h

Atual

Mín

36.64

Máximo

38.84

Indicadores-chave

By Trading Economics

Rendimento

-7.5M

-2M

Vendas

3.4M

314M

P/E

Médio do Setor

912.5

110.024

EPS

0.51

Margem de lucro

-0.645

Funcionários

3,600

EBITDA

-10M

21M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+59.45% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-560M

1.7B

Abertura anterior

35.16

Fecho anterior

38.59

Sentimento de Notícias

By Acuity

50%

50%

165 / 351 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

18 de fev. de 2026, 22:31 UTC

Ganhos

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18 de fev. de 2026, 22:18 UTC

Ganhos

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18 de fev. de 2026, 22:11 UTC

Ganhos

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18 de fev. de 2026, 21:52 UTC

Ganhos

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18 de fev. de 2026, 23:56 UTC

Conversa de Mercado

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18 de fev. de 2026, 23:46 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

18 de fev. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18 de fev. de 2026, 23:34 UTC

Conversa de Mercado
Ganhos

Brambles' Cost Control Stands Out to Bull -- Market Talk

18 de fev. de 2026, 23:33 UTC

Conversa de Mercado

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18 de fev. de 2026, 23:32 UTC

Conversa de Mercado

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18 de fev. de 2026, 22:45 UTC

Ganhos

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18 de fev. de 2026, 22:44 UTC

Conversa de Mercado

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18 de fev. de 2026, 22:37 UTC

Ganhos

Nutrien 4Q EPS $1.18 >NTR.T

18 de fev. de 2026, 22:37 UTC

Ganhos

Nutrien 4Q Sales $5.34B >NTR.T

18 de fev. de 2026, 22:35 UTC

Ganhos

Pan American Silver 4Q EPS $1.07 >PAAS

18 de fev. de 2026, 22:35 UTC

Ganhos

Pan American Silver 4Q Rev $1.18B >PAAS

18 de fev. de 2026, 22:30 UTC

Ganhos

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18 de fev. de 2026, 22:29 UTC

Ganhos

Kinross Gold 4Q EPS 75c >K.T

18 de fev. de 2026, 22:22 UTC

Ganhos

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18 de fev. de 2026, 22:22 UTC

Conversa de Mercado

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18 de fev. de 2026, 22:16 UTC

Ganhos

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18 de fev. de 2026, 22:05 UTC

Ganhos

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18 de fev. de 2026, 22:03 UTC

Ganhos

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18 de fev. de 2026, 22:02 UTC

Ganhos

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18 de fev. de 2026, 22:02 UTC

Ganhos

Kaiser Aluminum 4Q Sales $929M >KALU

18 de fev. de 2026, 22:02 UTC

Ganhos

Kaiser Aluminum 4Q EPS $1.68 >KALU

18 de fev. de 2026, 22:00 UTC

Ganhos

Kinross Gold 4Q Adj EPS 67c >KGC

18 de fev. de 2026, 22:00 UTC

Ganhos

Kinross Gold 4Q Sales $2.02B >KGC

18 de fev. de 2026, 21:56 UTC

Ganhos

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

59.45% parte superior

Previsão para 12 meses

Média 58.2 USD  59.45%

Máximo 70 USD

Mínimo 49 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

7 ratings

6

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

165 / 351 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat